Send this to a friend

Biostage misses 3Q filing deadline due to financial woes

Hollistion biotech manufacturer Biostage has notified the U.S. Securities and Exchange Commission its third-quarter report will be late.
The notification comes just a month after the company laid off 17 of its 24 employees after it was Back to article

Fields marked in red are required
Your name
Your email
Recipient addresses
(Separate multiple addresses with commas)

Personal message

Copyright 2017 New England Business Media